Eagle Bay Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-17
Closed -$7.03K 517
2024
Q4
$7.03K Hold
17
﹤0.01% 626
2024
Q3
$8.59K Hold
17
﹤0.01% 818
2024
Q2
$8.28K Buy
17
+5
+42% +$2.51K 0.01% 599
2024
Q1
$6.48K Buy
+12
New +$6.56K ﹤0.01% 664
2022
Q1
Sell
-178
Closed -$117K 599
2021
Q4
$117K Sell
178
-9
-5% -$5.65K 0.07% 158
2021
Q3
$116K Buy
187
+10
+6% +$6.72K 0.07% 210
2021
Q2
$113K Buy
+177
New +$97.7K 0.09% 136

Other funds holding IDXX

Eagle Bay Advisors's IDXX Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 17 shares — an estimated $7.03K sold.

Eagle Bay Advisors first reported a position in IDXX in Q2 2021 and held it in 7 quarters. The position peaked at $117K in Q4 2021. 1,144 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 17 Idexx Laboratories shares in Q1 2025, an estimated $7.03K.
  • Eagle Bay Advisors first reported a position in Idexx Laboratories in Q2 2021 and held it in 7 quarters.
  • Eagle Bay Advisors's Idexx Laboratories position peaked at $117K in Q4 2021.
  • 1,144 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.